B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

POLH

MOLECULAR TARGET

DNA polymerase eta

UniProt: Q9Y253NCBI Gene: 542922 compounds

POLH (DNA polymerase eta) is targeted by 22 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting POLH

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1myricetin-3-O-galactopyranoside [Supplementary Concept]1.393
2Aurintricarboxylic Acid1.393
3alpha-Linolenic Acid1.102
4Cefixime1.102
5Diiodotyrosine1.102
6gamma-Linolenic Acid1.102
7Levodopa1.102
8Kaempferols0.691
9Luteolin 5,7,3',4'-tetrahydroxy-flavone,0.691
10Quercetin0.691
11ag4900.691
12Methotrexate0.691
13Ampicillin Semi-synthetic derivative of penicillin that functions as0.691
14Cefotetan0.691
15Ethidium0.691
16Hexachlorophene0.691
17Idarubicin0.691
18Masoprocol0.691
19Norepinephrine Precursor of epinephrine that is secreted by0.691
20Oxytetracycline0.691
21piceatannol0.691
22streptonigrin0.691

About POLH as a Drug Target

POLH (DNA polymerase eta) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 22 compounds with documented POLH interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

POLH inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.